News and Announcements
Peppermint Launches MyWeps Mobile Remittance App in the Philippines
- Published May 31, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Peppermint Innovation Ltd (ASX:PIL) is pleased to announce that the commercial pilot of the MyWeps Mobile Remittance app, powered by Peppermint’s Mobile Agent Remittance platform has commenced today, in partnership with MyWeps International Inc.
KEY TAKEAWAYS:
- An initial cohort of 278 agents have commenced pilot testing of the MyWeps Mobile Remittance app, powered by Peppermint’s Mobile Agent Remittance platform
- Shortly, 500 agents in total will be on-boarded to take part in the three-month pilot
- The pilot will take place across the National Capital Region (NCR), key regional areas plus six specific municipalities in provinces identified as marginalised or underserved areas by the BSP’s Inclusive Financial Advisory (IFAS)
- This is a significant milestone for the Company, as it works towards commercialising its non-banked offering to promote financial inclusion in the Philippines
Chris Kain, Managing Director & CEO comments: “We’re extremely pleased to be kicking off this MyWeps pilot which represents a significant milestone for our Company, as the culmination of close to 2 years worth of work. This is a huge step forward on the path to a full scale commercial launch of this technology.”
Rico D Lorredo, Chairman and CEO, MyWeps International Inc. states: “We, along with our agents are really pleased this pilot is underway and excited to be able to offer such a great extension of our services to our customers. We anticipate a strong positive response to this pilot and are proud to be part of this pilot, which is an important step towards providing financial inclusiveness for Filipinos.”
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
